Olema Pharmaceuticals, Inc. - Common Stock (OLMA)

Historical Holders from Q4 2020 to Q3 2025

Symbol
OLMA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
68,958,635
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
68,238,525
Holdings value
$668,035,985
% of all portfolios
0.001%
Number of holders
123
Number of buys
59
Number of sells
-51
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Olema Pharmaceuticals, Inc. - Common Stock (OLMA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Paradigm Biocapital Advisors LP 9.99% $37,443,949 7,429,355 Paradigm BioCapital Advisors LP 31 Dec 2024
Bain Capital Life Sciences Opportunities IV, L.P. 9.99% 0% $34,493,528 -$1,269,203 6,843,954 -3.5% Bain Capital Life Sciences Opportunities IV, L.P. 31 Mar 2025
JANUS HENDERSON GROUP PLC 5.2% $35,105,462 3,585,849 JANUS HENDERSON GROUP PLC 30 Sep 2025
Deep Track Capital, LP 5.04% $17,351,878 3,442,833 Deep Track Capital, LP 31 Mar 2025
Logos Global Management LP 4.7% $16,172,730 3,208,875 Logos Global Management LP 18 Mar 2025
Point72 Asset Management, L.P. 2.3% $7,781,412 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025

Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 68,238,525 $668,035,985 -$3,229,145 $9.79 123
2025 Q2 70,511,948 $300,429,144 +$22,565,282 $4.26 120
2025 Q1 65,888,228 $247,927,417 -$30,654,965 $3.76 131
2024 Q4 71,278,859 $415,382,388 +$48,509,843 $5.83 154
2024 Q3 58,658,581 $700,332,942 +$12,555,131 $11.94 129
2024 Q2 57,896,539 $626,445,097 +$18,080,243 $10.82 127
2024 Q1 56,110,675 $635,162,151 +$37,635,929 $11.32 125
2023 Q4 51,618,204 $717,066,039 +$56,526,765 $14.03 113
2023 Q3 47,322,813 $584,436,985 +$135,063,720 $12.35 97
2023 Q2 36,408,086 $328,764,561 +$43,216,272 $9.03 86
2023 Q1 33,447,196 $116,103,891 +$1,469,913 $3.47 65
2022 Q4 33,334,567 $81,640,055 -$481,138 $2.45 66
2022 Q3 33,359,693 $92,063,140 -$4,143,577 $2.76 67
2022 Q2 34,202,982 $139,234,855 -$8,391,103 $4.07 70
2022 Q1 36,374,849 $155,206,361 -$17,958,891 $4.26 86
2021 Q4 38,428,075 $359,510,482 -$41,441,250 $9.36 94
2021 Q3 36,741,334 $1,012,524,920 -$19,680,898 $27.56 75
2021 Q2 37,428,321 $1,047,268,923 +$59,576,299 $27.98 68
2021 Q1 35,240,926 $1,158,274,244 -$1,710,105 $33.18 73
2020 Q4 35,073,865 $1,657,230,008 +$1,657,206,010 $48.08 56